UiPath (NYSE: PATH) is on the path to a full market reversal because its March price pullback is an irrational response to good news. The company's Q4 fiscal year 2026 (FY2026) results topped ...

UiPath (NYSE:PATH) has launched agentic AI automation tools tailored for healthcare providers and payers. The company is partnering with Genzeon to target data management and revenue cycle workflows.

Financial crime compliance is one of banking's most stubborn operational problems - creating high alert volumes, scarce ...

UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...

UiPath (NYSE:PATH) is preparing to release its quarterly earnings on Wednesday, 2025-12-03. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Automation has evolved. Where a decade ago we were happy (if not positively exhilarated) to talk about the application of intelligent document processing and robotic process automation as progressive ...